FDA
- Status: approved
Phase 2: Optional ETN, SSZ, HCQ, MTX (Phase 2: Optional ETN, SSZ, HCQ, MTX) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.